1.66 USD
▲+0.02+1.22%
盘后 1.63 -0.61%
2026-08-03
市值
$176.64M
市盈率
—
EPS
-0.45
股息率
—
52 周区间
1.58 – 6.30
成交量
362.72K
Beta
0.69
目标价
10.60
52W 低 1.5852W 高 6.30
价格走势
公司简介
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company’s lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer’s disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Co...